EP2814469
Stýrð losun hýdrókortísónsamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.2.2013EP published:
8.4.2020EP application number:
13709499.1
EP translation filed:
5.5.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
11.2.2033Expiry date:
11.2.2027Next due date:
28.2.2027
Title:
HYDROCORTISONE CONTROLLED RELEASE FORMULATION
Timeline
Today
12.2.2013EP application
8.4.2020EP Publication
5.5.2020Translation submitted
15.5.2020Registration published
11.2.2027Expires
Owner
Name:
Neurocrine UK LimitedAddress:
Cardiff MediCentre, Heath ParkCardiffCF14 4UJ, GB
Inventor
Name:
HUATAN, HiepAddress:
Cardiff CF14 4UJ, GB
Name:
ROSS, RichardAddress:
Cardiff CF14 4UJ, GB
Name:
WHITAKER, MartinAddress:
Cardiff CF14 4UJ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201202433Date:
13.2.2012Country:
GB
Number:
201261599704 PDate:
16.2.2012Country:
US
Number:
201261600958 PDate:
20.2.2012Country:
US
Classification
Categories:
A61K 9/50, A61K 31/573
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 29.1.2021
Expires: 11.2.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.2.2022
Expires: 11.2.2023
Payer: The International Renewals Group Inc.
Number: 11
Paid: 31.1.2023
Expires: 11.2.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 18.1.2024
Expires: 11.2.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 20.1.2025
Expires: 11.2.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 30.1.2026
Expires: 11.2.2027
Payer: Árnason Faktor ehf.